Literature DB >> 16715101

Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation.

Seiichi Kuwajima1, Taku Sato, Kazuto Ishida, Hiroyuki Tada, Hiroyuki Tezuka, Toshiaki Ohteki.   

Abstract

The function of interleukin 15 (IL-15) in unmethylated CpG oligodeoxynucleotide (CpG)-induced immune responses remains unknown. Here, in response to CpG, both wild-type and natural killer cell-depleted mice produced IL-12 and became resistant to a lethal dose of Listeria monocytogenes. In contrast, CpG-treated IL-15-deficient mice produced little IL-12 and succumbed to L. monocytogenes. CpG-stimulated conventional dendritic cells (cDCs) were the main producers of both IL-15 and IL-12, but cDCs did not produce IL-12 in the absence of plasmacytoid DCs (pDCs). The cDC-derived IL-15 induced CD40 expression by cDCs. Interaction between CD40 on cDCs and CD40 ligand on pDCs led to IL-12 production by cDCs. Thus, IL-15-dependent crosstalk between cDCs and pDCs is essential for CpG-induced immune activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715101     DOI: 10.1038/ni1348

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  65 in total

1.  Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia.

Authors:  Vijay Saxena; Pranavkumar Shivakumar; Gregg Sabla; Reena Mourya; Claire Chougnet; Jorge A Bezerra
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

Review 2.  Division of labor, plasticity, and crosstalk between dendritic cell subsets.

Authors:  Bali Pulendran; Hua Tang; Timothy L Denning
Journal:  Curr Opin Immunol       Date:  2007-12-21       Impact factor: 7.486

3.  The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses.

Authors:  S-A Shu; Z-X Lian; Y-H Chuang; G-X Yang; Y Moritoki; S S Comstock; R-Q Zhong; A A Ansari; Y-J Liu; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

Review 4.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

5.  Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation.

Authors:  Joshua J Obar; Evan R Jellison; Brian S Sheridan; David A Blair; Quynh-Mai Pham; Julianne M Zickovich; Leo Lefrançois
Journal:  J Immunol       Date:  2011-10-10       Impact factor: 5.422

Review 6.  New insights into IL-12-mediated tumor suppression.

Authors:  S Tugues; S H Burkhard; I Ohs; M Vrohlings; K Nussbaum; J Vom Berg; P Kulig; B Becher
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

7.  Slc15a4 function is required for intact class switch recombination to IgG2c in response to TLR9 stimulation.

Authors:  Pia Dosenovic; Monika Ádori; William C Adams; Gabriel K Pedersen; Martina Soldemo; Bruce Beutler; Gunilla B Karlsson Hedestam
Journal:  Immunol Cell Biol       Date:  2014-10-14       Impact factor: 5.126

8.  Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.

Authors:  Stefan Nierkens; Martijn H den Brok; Thijs Roelofsen; Jori A L Wagenaars; Carl G Figdor; Theo J Ruers; Gosse J Adema
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

9.  IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.

Authors:  Simone Haeberlein; Heidi Sebald; Christian Bogdan; Ulrike Schleicher
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

10.  Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection.

Authors:  Heung Kyu Lee; Melodie Zamora; Melissa M Linehan; Norifumi Iijima; David Gonzalez; Ann Haberman; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.